# Annual Study to Investigate Influenza Vaccine Due to New Virus Strains for the 2007/2008 Influenza Season in Europe

> **NCT00479921** · PHASE3 · COMPLETED · sponsor: **Solvay Pharmaceuticals** · enrollment: 120 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** Trivalent influenza subunit vaccine

## Key facts

- **NCT ID:** NCT00479921
- **Lead sponsor:** Solvay Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2009-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00479921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00479921, "Annual Study to Investigate Influenza Vaccine Due to New Virus Strains for the 2007/2008 Influenza Season in Europe". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT00479921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*